Lucid Diagnostics Inc.LUCDNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+29.4%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+29.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20247.67+130.1%
2023-25.48-1293.6%
20222.13-39.7%
20213.54+111.0%
2020-32.18+60.7%
2019-81.94+80.0%
2018-409.37-